中国è¯ç†å­¦ä¼š
会员中心 | è”系我们
 
首页

中国è¯ç†å­¦ä¼šæŠ—è¡°è€ä¸Žè€å¹´ç—´å‘†ä¸“业委员会

æ¥æºï¼šä¸­å›½è¯ç†å­¦ä¼šç½‘     字å·:[大] [中] [ å°]    打å°

抗衰è€ä¸Žè€å¹´ç—´å‘†ä¸“业委员会是中国è¯ç†å­¦ä¼šçš„附属机构,以1998年建立的中国è€å¹´æ€§ç—´å‘†ç§‘学家学会为基础,于2004年由国家民政部批准æˆç«‹ã€‚本专业委员会紧密èžåˆè¯ç†å­¦ã€ç¥žç»ç§‘å­¦ã€ä¸´åºŠåŒ»å­¦ã€è¯å­¦ã€æµè¡Œç—…å­¦åŠåˆ†å­ç”Ÿç‰©å­¦ç­‰å¤šé¢†åŸŸå‰æ²¿çŸ¥è¯†ï¼Œå±•现出独特的跨学科èžåˆç‰¹è‰²ã€‚

在中国è¯ç†å­¦ä¼šçš„领导下,本专业委员会始终将学术交æµä¸ŽæŽ¢ç´¢ä½œä¸ºæ ¸å¿ƒä½¿å‘½ï¼Œæ±‡èšäº†å…¨å›½æŠ—è¡°è€ä¸Žè€å¹´ç—´å‘†ç ”究领域的æ°å‡ºåŸºç¡€ä¸Žä¸´åºŠå­¦è€…。从1998年开始,本专业委员会已ç»ä¸¾åŠžäº†19届全国性抗衰è€ä¸Žè€å¹´ç—´å‘†å­¦æœ¯ä¼šè®®ã€‚通过广泛而深入的国内外学术交æµä¸Žåˆä½œï¼Œä¸æ–­æŽ¨åŠ¨æˆ‘å›½åœ¨è¯¥é¢†åŸŸçš„åŸºç¡€ç ”ç©¶ä¸Žä¸´åºŠå¹²é¢„æ°´å¹³è¾¾åˆ°æ–°çš„é«˜åº¦ã€‚åŒæ—¶ï¼Œæˆ‘们注é‡äººæ‰åŸ¹å…»ã€ç§‘ç ”åŸºåœ°å»ºè®¾ä»¥åŠæ–°è¯ç ”å‘与创新工作,为应对人å£è€é¾„化带æ¥çš„æŒ‘战贡献科学力é‡ã€‚

æœ¬ä¸“ä¸šå§”å‘˜ä¼šå……åˆ†å‘æŒ¥å¤šå­¦ç§‘交å‰çš„优势,以è¯ç†å­¦ä¸ºåŸºçŸ³ï¼Œèžåˆè¥¿åŒ»ä¸Žä¸­åŒ»çš„æ™ºæ…§ï¼Œæ·±å…¥æŽ¢è®¨è¡°è€ä¸Žè€å¹´ç—´å‘†çš„夿‚å‘ç—…æœºåˆ¶ã€æ—©æœŸç²¾å‡†è¯Šæ–­æ–¹æ³•ã€æœ‰æ•ˆä¸´åºŠå¹²é¢„策略以åŠåˆ›æ–°è¯ç‰©æ²»ç–—çš„æ–°è·¯å¾„ä¸Žæ–°æŽªæ–½ã€‚æ­¤å¤–ï¼Œæœ¬ä¸“ä¸šå§”å‘˜ä¼šè¿˜ç§¯æžæŠ•èº«äºŽç§‘æ™®å®£ä¼ äº‹ä¸šï¼Œè‡´åŠ›äºŽå°†ç§‘å­¦çš„æŠ—è¡°è€ä¸Žè€å¹´ç—´å‘†çŸ¥è¯†æ™®åŠè‡³å¹¿å¤§æ°‘众。æ¯å¹´9月21日国际è€å¹´ç—´å‘†æ—¥ï¼Œæˆ‘ä»¬éƒ½ä¼šæºæ‰‹å…¶ä»–学会,组织专家ã€ä¸´åºŠåŒ»ç”Ÿå’Œè¯å¸ˆå…±åŒä¸¾åŠžç§‘æ™®å®£ä¼ å’Œä¹‰è¯Šæ´»åŠ¨ï¼Œæ·±å—广大患者åŠå®¶å±žçš„æ¬¢è¿Žï¼Œå·²æˆä¸ºå…·æœ‰å¹¿æ³›å½±å“力和良好å£ç¢‘çš„å“牌科普活动。

The Committee on Anti-Aging and Alzheimer's Disease, an affiliated institution of the Chinese Pharmacological Society, was formally established in 2004 with approval from the Ministry of Civil Affairs of China. This professional committee evolved from the Chinese Society of Alzheimer's Disease Scientists founded in 1998, and has developed distinctive interdisciplinary characteristics by integrating cutting-edge knowledge across pharmacology, neuroscience, clinical medicine, pharmacy, epidemiology, and molecular biology.

Under the guidance of the Chinese Pharmacological Society, the committee has consistently prioritized academic exchange and scientific exploration, assembling distinguished scholars in both basic and clinical research domains of anti-aging and Alzheimer's disease (AD) nationwide. Since 1998, it has successfully convened 19 national academic conferences on anti-aging and Alzheimer's disease. Through extensive domestic and international collaborations, the committee has significantly advanced fundamental research and clinical intervention capabilities in this field. Concurrently, it emphasizes talent cultivation, research infrastructure development, and innovative drug discovery, thereby providing scientific solutions to address challenges posed by population aging.

Leveraging multidisciplinary synergies with pharmacological foundations, the committee systematically investigates the complex pathogenesis of aging and dementia, develops precision diagnostic methodologies, formulates effective clinical intervention strategies, and explores novel therapeutic approaches integrating Western and Traditional Chinese Medicine paradigms. Furthermore, the committee actively engages in science communication initiatives, particularly through annual public education campaigns coinciding with World Alzheimer's Day on September 21. These collaborative events with partner organizations, featuring expert lectures and free medical consultations by clinicians and pharmacists, have evolved into influential public service programs receiving widespread public recognition.

组织机构
中国è¯ç†å­¦ä¼š
京ICP备18017554å·-2 | 京公网安备 11010202007922å·
2025 中国è¯ç†å­¦ä¼š ç‰ˆæƒæ‰€æœ‰ 未ç»å…许 ä¸å¾—转载 | è”系我们 | æ„è§å馈
地å€ï¼šåŒ—京市西城区å—纬路甲2å·
邮政编ç ï¼š100050
勿ƒ…链接

中国è¯ç†å­¦ä¼š 微信二维ç å…¬ä¼—å·